1 Ustekinumab Market Overview 1.1 Product Overview and Scope of Ustekinumab 1.2 Ustekinumab Segment by Type 1.2.1 Global Ustekinumab Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Intravenous 1.2.3 Subcutaneous 1.3 Ustekinumab Segment by Application 1.3.1 Global Ustekinumab Sales Comparison by Application: (2022-2028) 1.3.2 Arthritis 1.3.3 Colitis 1.3.4 Lupus Erythematosus 1.3.5 Myositis Multiplex With Palmoplantar Pustulosis 1.3.6 Cirrhosis Of The Liver 1.3.7 Sarcoidosis 1.3.8 Diabetes 1.3.9 Other 1.4 Global Ustekinumab Market Size Estimates and Forecasts 1.4.1 Global Ustekinumab Revenue 2017-2028 1.4.2 Global Ustekinumab Sales 2017-2028 1.4.3 Ustekinumab Market Size by Region: 2017 Versus 2021 Versus 2028 2 Ustekinumab Market Competition by Manufacturers 2.1 Global Ustekinumab Sales Market Share by Manufacturers (2017-2022) 2.2 Global Ustekinumab Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Ustekinumab Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Ustekinumab Manufacturing Sites, Area Served, Product Type 2.5 Ustekinumab Market Competitive Situation and Trends 2.5.1 Ustekinumab Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Ustekinumab Players Market Share by Revenue 2.5.3 Global Ustekinumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Ustekinumab Retrospective Market Scenario by Region 3.1 Global Ustekinumab Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Ustekinumab Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Ustekinumab Market Facts & Figures by Country 3.3.1 North America Ustekinumab Sales by Country 3.3.2 North America Ustekinumab Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Ustekinumab Market Facts & Figures by Country 3.4.1 Europe Ustekinumab Sales by Country 3.4.2 Europe Ustekinumab Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Ustekinumab Market Facts & Figures by Region 3.5.1 Asia Pacific Ustekinumab Sales by Region 3.5.2 Asia Pacific Ustekinumab Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Ustekinumab Market Facts & Figures by Country 3.6.1 Latin America Ustekinumab Sales by Country 3.6.2 Latin America Ustekinumab Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Ustekinumab Market Facts & Figures by Country 3.7.1 Middle East and Africa Ustekinumab Sales by Country 3.7.2 Middle East and Africa Ustekinumab Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Ustekinumab Historic Market Analysis by Type 4.1 Global Ustekinumab Sales Market Share by Type (2017-2022) 4.2 Global Ustekinumab Revenue Market Share by Type (2017-2022) 4.3 Global Ustekinumab Price by Type (2017-2022) 5 Global Ustekinumab Historic Market Analysis by Application 5.1 Global Ustekinumab Sales Market Share by Application (2017-2022) 5.2 Global Ustekinumab Revenue Market Share by Application (2017-2022) 5.3 Global Ustekinumab Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Meiji 6.1.1 Meiji Corporation Information 6.1.2 Meiji Description and Business Overview 6.1.3 Meiji Ustekinumab Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Meiji Ustekinumab Product Portfolio 6.1.5 Meiji Recent Developments/Updates 6.2 Johnson & Johnson 6.2.1 Johnson & Johnson Corporation Information 6.2.2 Johnson & Johnson Description and Business Overview 6.2.3 Johnson & Johnson Ustekinumab Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Johnson & Johnson Ustekinumab Product Portfolio 6.2.5 Johnson & Johnson Recent Developments/Updates 6.3 Alvotech 6.3.1 Alvotech Corporation Information 6.3.2 Alvotech Description and Business Overview 6.3.3 Alvotech Ustekinumab Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Alvotech Ustekinumab Product Portfolio 6.3.5 Alvotech Recent Developments/Updates 6.4 Fuji Pharma 6.4.1 Fuji Pharma Corporation Information 6.4.2 Fuji Pharma Description and Business Overview 6.4.3 Fuji Pharma Ustekinumab Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Fuji Pharma Ustekinumab Product Portfolio 6.4.5 Fuji Pharma Recent Developments/Updates 6.5 Mitsubishi Tanabe 6.5.1 Mitsubishi Tanabe Corporation Information 6.5.2 Mitsubishi Tanabe Description and Business Overview 6.5.3 Mitsubishi Tanabe Ustekinumab Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Mitsubishi Tanabe Ustekinumab Product Portfolio 6.5.5 Mitsubishi Tanabe Recent Developments/Updates 6.6 Stada 6.6.1 Stada Corporation Information 6.6.2 Stada Description and Business Overview 6.6.3 Stada Ustekinumab Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Stada Ustekinumab Product Portfolio 6.6.5 Stada Recent Developments/Updates 6.7 EPIRUS BioPharma 6.6.1 EPIRUS BioPharma Corporation Information 6.6.2 EPIRUS BioPharma Description and Business Overview 6.6.3 EPIRUS BioPharma Ustekinumab Sales, Revenue and Gross Margin (2017-2022) 6.4.4 EPIRUS BioPharma Ustekinumab Product Portfolio 6.7.5 EPIRUS BioPharma Recent Developments/Updates 6.8 Formycon 6.8.1 Formycon Corporation Information 6.8.2 Formycon Description and Business Overview 6.8.3 Formycon Ustekinumab Sales, Revenue and Gross Margin (2017-2022) 6.8.4 Formycon Ustekinumab Product Portfolio 6.8.5 Formycon Recent Developments/Updates 6.9 NeuClone 6.9.1 NeuClone Corporation Information 6.9.2 NeuClone Description and Business Overview 6.9.3 NeuClone Ustekinumab Sales, Revenue and Gross Margin (2017-2022) 6.9.4 NeuClone Ustekinumab Product Portfolio 6.9.5 NeuClone Recent Developments/Updates 6.10 Outlook Therapeutics 6.10.1 Outlook Therapeutics Corporation Information 6.10.2 Outlook Therapeutics Description and Business Overview 6.10.3 Outlook Therapeutics Ustekinumab Sales, Revenue and Gross Margin (2017-2022) 6.10.4 Outlook Therapeutics Ustekinumab Product Portfolio 6.10.5 Outlook Therapeutics Recent Developments/Updates 6.11 Harvest Moon Pharma 6.11.1 Harvest Moon Pharma Corporation Information 6.11.2 Harvest Moon Pharma Ustekinumab Description and Business Overview 6.11.3 Harvest Moon Pharma Ustekinumab Sales, Revenue and Gross Margin (2017-2022) 6.11.4 Harvest Moon Pharma Ustekinumab Product Portfolio 6.11.5 Harvest Moon Pharma Recent Developments/Updates 6.12 BioXpress 6.12.1 BioXpress Corporation Information 6.12.2 BioXpress Ustekinumab Description and Business Overview 6.12.3 BioXpress Ustekinumab Sales, Revenue and Gross Margin (2017-2022) 6.12.4 BioXpress Ustekinumab Product Portfolio 6.12.5 BioXpress Recent Developments/Updates 7 Ustekinumab Manufacturing Cost Analysis 7.1 Ustekinumab Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Ustekinumab 7.4 Ustekinumab Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Ustekinumab Distributors List 8.3 Ustekinumab Customers 9 Ustekinumab Market Dynamics 9.1 Ustekinumab Industry Trends 9.2 Ustekinumab Market Drivers 9.3 Ustekinumab Market Challenges 9.4 Ustekinumab Market Restraints 10 Global Market Forecast 10.1 Ustekinumab Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Ustekinumab by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Ustekinumab by Type (2023-2028) 10.2 Ustekinumab Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Ustekinumab by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Ustekinumab by Application (2023-2028) 10.3 Ustekinumab Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Ustekinumab by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Ustekinumab by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Ustekinumab Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Ustekinumab Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Ustekinumab Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Ustekinumab Market Competitive Situation by Manufacturers in 2021 Table 5. Global Ustekinumab Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Ustekinumab Sales Market Share by Manufacturers (2017-2022) Table 7. Global Ustekinumab Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Ustekinumab Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Ustekinumab Average Price (US$/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Ustekinumab Manufacturing Sites and Area Served Table 11. Manufacturers Ustekinumab Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Ustekinumab by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ustekinumab as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Ustekinumab Sales by Region (2017-2022) & (K Units) Table 16. Global Ustekinumab Sales Market Share by Region (2017-2022) Table 17. Global Ustekinumab Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Ustekinumab Revenue Market Share by Region (2017-2022) Table 19. North America Ustekinumab Sales by Country (2017-2022) & (K Units) Table 20. North America Ustekinumab Sales Market Share by Country (2017-2022) Table 21. North America Ustekinumab Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Ustekinumab Revenue Market Share by Country (2017-2022) Table 23. Europe Ustekinumab Sales by Country (2017-2022) & (K Units) Table 24. Europe Ustekinumab Sales Market Share by Country (2017-2022) Table 25. Europe Ustekinumab Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Ustekinumab Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Ustekinumab Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Ustekinumab Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Ustekinumab Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Ustekinumab Revenue Market Share by Region (2017-2022) Table 31. Latin America Ustekinumab Sales by Country (2017-2022) & (K Units) Table 32. Latin America Ustekinumab Sales Market Share by Country (2017-2022) Table 33. Latin America Ustekinumab Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Ustekinumab Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Ustekinumab Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Ustekinumab Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Ustekinumab Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Ustekinumab Revenue Market Share by Country (2017-2022) Table 39. Global Ustekinumab Sales by Type (2017-2022) & (K Units) Table 40. Global Ustekinumab Sales Market Share by Type (2017-2022) Table 41. Global Ustekinumab Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Ustekinumab Revenue Share by Type (2017-2022) Table 43. Global Ustekinumab Price by Type (2017-2022) & (US$/Unit) Table 44. Global Ustekinumab Sales (K Units) by Application (2017-2022) Table 45. Global Ustekinumab Sales Market Share by Application (2017-2022) Table 46. Global Ustekinumab Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Ustekinumab Revenue Share by Application (2017-2022) Table 48. Global Ustekinumab Price by Application (2017-2022) & (US$/Unit) Table 49. Meiji Corporation Information Table 50. Meiji Description and Business Overview Table 51. Meiji Ustekinumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 52. Meiji Ustekinumab Product Table 53. Meiji Recent Developments/Updates Table 54. Johnson & Johnson Corporation Information Table 55. Johnson & Johnson Description and Business Overview Table 56. Johnson & Johnson Ustekinumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 57. Johnson & Johnson Ustekinumab Product Table 58. Johnson & Johnson Recent Developments/Updates Table 59. Alvotech Corporation Information Table 60. Alvotech Description and Business Overview Table 61. Alvotech Ustekinumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 62. Alvotech Ustekinumab Product Table 63. Alvotech Recent Developments/Updates Table 64. Fuji Pharma Corporation Information Table 65. Fuji Pharma Description and Business Overview Table 66. Fuji Pharma Ustekinumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 67. Fuji Pharma Ustekinumab Product Table 68. Fuji Pharma Recent Developments/Updates Table 69. Mitsubishi Tanabe Corporation Information Table 70. Mitsubishi Tanabe Description and Business Overview Table 71. Mitsubishi Tanabe Ustekinumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 72. Mitsubishi Tanabe Ustekinumab Product Table 73. Mitsubishi Tanabe Recent Developments/Updates Table 74. Stada Corporation Information Table 75. Stada Description and Business Overview Table 76. Stada Ustekinumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 77. Stada Ustekinumab Product Table 78. Stada Recent Developments/Updates Table 79. EPIRUS BioPharma Corporation Information Table 80. EPIRUS BioPharma Description and Business Overview Table 81. EPIRUS BioPharma Ustekinumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 82. EPIRUS BioPharma Ustekinumab Product Table 83. EPIRUS BioPharma Recent Developments/Updates Table 84. Formycon Corporation Information Table 85. Formycon Description and Business Overview Table 86. Formycon Ustekinumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 87. Formycon Ustekinumab Product Table 88. Formycon Recent Developments/Updates Table 89. NeuClone Corporation Information Table 90. NeuClone Description and Business Overview Table 91. NeuClone Ustekinumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 92. NeuClone Ustekinumab Product Table 93. NeuClone Recent Developments/Updates Table 94. Outlook Therapeutics Corporation Information Table 95. Outlook Therapeutics Description and Business Overview Table 96. Outlook Therapeutics Ustekinumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 97. Outlook Therapeutics Ustekinumab Product Table 98. Outlook Therapeutics Recent Developments/Updates Table 99. Harvest Moon Pharma Corporation Information Table 100. Harvest Moon Pharma Description and Business Overview Table 101. Harvest Moon Pharma Ustekinumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 102. Harvest Moon Pharma Ustekinumab Product Table 103. Harvest Moon Pharma Recent Developments/Updates Table 104. BioXpress Corporation Information Table 105. BioXpress Description and Business Overview Table 106. BioXpress Ustekinumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 107. BioXpress Ustekinumab Product Table 108. BioXpress Recent Developments/Updates Table 109. Production Base and Market Concentration Rate of Raw Material Table 110. Key Suppliers of Raw Materials Table 111. Ustekinumab Distributors List Table 112. Ustekinumab Customers List Table 113. Ustekinumab Market Trends Table 114. Ustekinumab Market Drivers Table 115. Ustekinumab Market Challenges Table 116. Ustekinumab Market Restraints Table 117. Global Ustekinumab Sales Forecast by Type (2023-2028) & (K Units) Table 118. Global Ustekinumab Sales Market Share Forecast by Type (2023-2028) Table 119. Global Ustekinumab Revenue Forecast by Type (2023-2028) & (US$ Million) Table 120. Global Ustekinumab Revenue Market Share Forecast by Type (2023-2028) Table 121. Global Ustekinumab Sales Forecast by Application (2023-2028) & (K Units) Table 122. Global Ustekinumab Sales Market Share Forecast by Application (2023-2028) Table 123. Global Ustekinumab Revenue Forecast by Application (2023-2028) & (US$ Million) Table 124. Global Ustekinumab Revenue Market Share Forecast by Application (2023-2028) Table 125. Global Ustekinumab Sales Forecast by Region (2023-2028) & (K Units) Table 126. Global Ustekinumab Sales Market Share Forecast by Region (2023-2028) Table 127. Global Ustekinumab Revenue Forecast by Region (2023-2028) & (US$ Million) Table 128. Global Ustekinumab Revenue Market Share Forecast by Region (2023-2028) Table 129. Research Programs/Design for This Report Table 130. Key Data Information from Secondary Sources Table 131. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Ustekinumab Figure 2. Global Ustekinumab Market Share by Type in 2021 & 2028 Figure 3. Intravenous Product Picture Figure 4. Subcutaneous Product Picture Figure 5. Global Ustekinumab Market Share by Application in 2021 & 2028 Figure 6. Arthritis Figure 7. Colitis Figure 8. Lupus Erythematosus Figure 9. Myositis Multiplex With Palmoplantar Pustulosis Figure 10. Cirrhosis Of The Liver Figure 11. Sarcoidosis Figure 12. Diabetes Figure 13. Other Figure 14. Global Ustekinumab Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Ustekinumab Market Size (2017-2028) & (US$ Million) Figure 16. Global Ustekinumab Sales (2017-2028) & (K Units) Figure 17. Ustekinumab Sales Share by Manufacturers in 2021 Figure 18. Global Ustekinumab Revenue Share by Manufacturers in 2021 Figure 19. The Global 5 and 10 Largest Ustekinumab Players: Market Share by Revenue in 2021 Figure 20. Ustekinumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 21. Global Ustekinumab Sales Market Share by Region (2017-2022) Figure 22. Global Ustekinumab Sales Market Share by Region in 2021 Figure 23. Global Ustekinumab Revenue Market Share by Region (2017-2022) Figure 24. Global Ustekinumab Revenue Market Share by Region in 2021 Figure 25. U.S. Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Canada Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. Germany Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. France Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. U.K. Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. Italy Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. Russia Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. China Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Japan Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. South Korea Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. India Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Australia Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Taiwan Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Indonesia Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Thailand Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Malaysia Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Philippines Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Vietnam Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Mexico Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. Brazil Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Argentina Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 46. Turkey Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 47. Saudi Arabia Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 48. UAE Ustekinumab Revenue Growth Rate (2017-2022) & (US$ Million) Figure 49. Sales Market Share of Ustekinumab by Type (2017-2022) Figure 50. Manufacturing Cost Structure of Ustekinumab Figure 51. Manufacturing Process Analysis of Ustekinumab Figure 52. Ustekinumab Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Meiji Johnson & Johnson Alvotech Fuji Pharma Mitsubishi Tanabe Stada EPIRUS BioPharma Formycon NeuClone Outlook Therapeutics Harvest Moon Pharma BioXpress